Discovery of DNA methylation signature in the peripheral blood of individuals with history of antenatal exposure to valproic acid.

Saved in:
Bibliographic Details
Title: Discovery of DNA methylation signature in the peripheral blood of individuals with history of antenatal exposure to valproic acid.
Authors: Haghshenas S; Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON, Canada., Putoux A; Hospices Civils de Lyon, Service de Génétique, Bron, France; Centre de Recherche en Neurosciences de Lyon, Equipe GENDEV, INSERM U1028, UMR CNRS 5292, Université Claude Bernard Lyon 1, Lyon, France., Reilly J; Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada., Levy MA; Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON, Canada., Relator R; Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON, Canada., Ghosh S; Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada., Kerkhof J; Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON, Canada., McConkey H; Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON, Canada; Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada., Edery P; Hospices Civils de Lyon, Service de Génétique, Bron, France; Centre de Recherche en Neurosciences de Lyon, Equipe GENDEV, INSERM U1028, UMR CNRS 5292, Université Claude Bernard Lyon 1, Lyon, France., Lesca G; Hospices Civils de Lyon, Service de Génétique, Bron, France; Institut NeuroMyoGène, CNRS UMR 5310 - INSERM U1217, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Besson A; Institut NeuroMyoGène, CNRS UMR 5310 - INSERM U1217, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Coubes C; Reference Centre for Rare Disease Developmental Anomaly and Malformative Syndromes, Genetic Clinic Unit, CHU Montpellier, Montpellier, France., Willems M; Reference Centre for Rare Disease Developmental Anomaly and Malformative Syndromes, Genetic Clinic Unit, CHU Montpellier, Montpellier, France., Ruiz-Pallares N; Laboratoire de Génétique des Maladies Rares et Autoinflammatoires, CHU Montpellier, Montpellier, France., Barat-Houari M; Laboratoire de Génétique des Maladies Rares et Autoinflammatoires, CHU Montpellier, Montpellier, France., Tizzano EF; Department of Clinical and Molecular Genetics, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Medicine Genetics Group Vall d'Hebron Research Institute (VHIR), Barcelona, Spain; European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA., Valenzuela I; Department of Clinical and Molecular Genetics, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Medicine Genetics Group Vall d'Hebron Research Institute (VHIR), Barcelona, Spain; European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA., Sabbagh Q; Reference Centre for Rare Disease Developmental Anomaly and Malformative Syndromes, Genetic Clinic Unit, CHU Montpellier, Montpellier, France., Clayton-Smith J; Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK., Jackson A; Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK., O'Sullivan J; Manchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK., Bromley R; Division of Neuroscience, School of Biological Sciences, Faculty of Medicine, Biology and Health, University of Manchester, UK; Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, UK., Banka S; Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK., Genevieve D; Reference Centre for Rare Disease Developmental Anomaly and Malformative Syndromes, Genetic Clinic Unit, CHU Montpellier, Montpellier, France; Montpellier University, Inserm U1183, Montpellier, France; European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA. Electronic address: d-genevieve@chu-montpellier.fr., Sadikovic B; Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON, Canada; Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada. Electronic address: bekim.sadikovic@lhsc.on.ca.
Source: Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2024 Oct; Vol. 26 (10), pp. 101226. Date of Electronic Publication: 2024 Jul 31.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 9815831 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0366 (Electronic) Linking ISSN: 10983600 NLM ISO Abbreviation: Genet Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-0366
DOI:10.1016/j.gim.2024.101226